Variation of inflammatory indexes after electrical cardioversion of persistent atrial fibrillation. Is there an association with early recurrence rates?

International Journal of Clinical Practice

Volumn 59, Issue 8, 2005, Pages 881-885

  Korantzopoulos, Panagiotis ^a,b   Kolettis, T M ^b   Kountouris, E ^a   Siogas, K ^a   Goudevenos, J A ^b  

^a UNIVERSITY OF IOANNINA   (Greece)

^b Division of Cardiology   (Greece)

Author keywords

Atrial fibrillation; Atrialre modeling; C reactive protein; Fibrinogen; Inflammation; White blood cell count

Indexed keywords

ACENOCOUMAROL; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; DIGOXIN; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FIBRINOGEN; BIOLOGICAL MARKER;

AGED; ARTICLE; CARDIOVERSION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG HALF LIFE; FEMALE; FIBRINOGEN BLOOD LEVEL; FOLLOW UP; HEART ATRIUM FIBRILLATION; HUMAN; INFLAMMATION; LEUKOCYTE COUNT; MALE; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE RISK; SINUS RHYTHM; STATISTICAL SIGNIFICANCE; VARIANCE; ANALYSIS OF VARIANCE; BLOOD; COMPARATIVE STUDY; ECHOCARDIOGRAPHY; ECHOGRAPHY; PROSPECTIVE STUDY; RECURRENT DISEASE;

AGED; ANALYSIS OF VARIANCE; ATRIAL FIBRILLATION; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; ECHOCARDIOGRAPHY; ELECTRIC COUNTERSHOCK; FEMALE; FIBRINOGEN; HUMANS; LEUKOCYTE COUNT; MALE; PROSPECTIVE STUDIES; RECURRENCE;

EID: 30344453303     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1368-5031.2005.00569.x     Document Type: Article

References (31)

1. Tsang TSM, Gersh BJ. Atrial fibrillation: An old disease, a new epidemic. Am J Med 2002; 113: 432-5.
2. Korantzopoulos P, Kolettis TM, Goudevenos JA, Siogas K. Errors and pitfalls in the non-invasive management of atrial fibrillation. Int J Cardiol (in press).
3. Benjamin EJ, Wolf PA, D'Agostino RB et al. Impact of atrial fibrillation on the risk of death: The Framingham Heart Study. Circulation 1998; 98: 946-52.
4. Allessie M, Ausma J, Schotten U. Electrical, contracticle and structural remodeling during atrial fibrillation. Cardiovasc Res 2002; 54: 230-46.
5. Tieleman RG, Van Gelder IC, Crijns HJGM et al. Early recurrences of atrial fibrillation after electrical cardioversion: A result of fibrillation-induced electrical remodeling of the atria? J Am Coll Cardiol 1998; 31: 167-73.
6. Frustaci A, Chimenti C, Bellocci F et al. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation 1997; 96: 1180-4.
7. Chung MK, Martin DO, Sprecher D et al. C-reactive protein elevation in patients with atrial arrhythmias: Inflammatory mechanisms and persistence of atrial fibrillation. Circulation 2001; 104: 2886-91.
8. Dernellis J, Panaretou M. C-reactive protein and paroxysmal atrial fibrillation: Evidence of the implication of an inflammatory process in paroxysmal atrial fibrillation. Acta Cardiol 2001; 56: 375-80.
9. Aviles RJ, Martin DO, Apperson-Hansen C et al. Inflammation as a risk factor for atrial fibrillation. Circulation 2003; 108: 3006-10.
10. Anderson JL, Maycock CA, Lappe DL et al. Frequency of elevation of C-reactive protein in atrial fibrillation. Am J Cardiol 2004; 94: 1255-9.
11. Asselbergs FW, van den Berg MP, Diercks GFH et al. C-reactive protein and microalbuminuria are associated with atrial fibrillation. Int J Cardiol 2005; 98: 73-7.
12. Conway DSG, Buggins P, Hughes E, Lip GYH. Predictive value of indices of inflammation and hypercoagulability on success of cardioversion of persistent atrial fibrillation. Am J Cardiol 2004; 94: 508-10.
13. Conway DSG, Buggins P, Hughes E, Lip GYH. Relation of interleukin-6, C-reactive protein, and the prothrombotic state to transesophageal echocardiographic findings in atrial fibrillation. Am J Cardiol 2004; 93: 1368-73.
14. Conway DSG, Buggins P, Hughes E, Lip GYH. Relationship of interleukin-6 and C-reactive protein to the prothrombotic state in chronic atrial fibrillation. J Am Coll Cardiol 2004; 43: 2075-82.
15. Thambidorai SK, Parakh K, Martin DO et al. Relation of C-reactive protein correlates with risk of thromboembolism in patients with atrial fibrillation. Am J Cardiol 2004; 94: 805-7.
16. Conway DSG, Buggins P, Hughes E, Lip GYH. Prognostic significance of raised plasma levels of interleukin-6 and C-reactive protein in atrial fibrillation. Am Heart J 2004; 148: 462-6.
17. Korantzopoulos P, Galaris D, Papaioannides D, Kokkoris S. C-reactive protein and oxidative stress in atrial fibrillation. Int J Cardiol 2003; 88: 103-4.
18. Korantzopoulos P, Kolettis T, Siogas K, Goudevenos J. Atrial fibrillation and electrical remodeling. the potential role of inflammation and oxidative stress. Med Sci Monit 2003; 9: RA225-9.
19. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999; 340: 448-54.
20. Bruins P, te Velthuis H, Yazdanbakhsh AP et al. Activation of the complement system during and after cardiopulmonary bypass surgery: postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia. Circulation 1997; 96: 3542-8.
21. Abdelhadi RH, Gurm HS, Van Wagoner DR, Chung MK. Relation of an exaggerated rise in white blood cells after coronary bypass or cardiac valve surgery to development of atrial fibrillation postoperatively. Am J Cardiol 2004; 93: 1176-8.
22. Li-Saw-Hee FL, Blann AD, Gurney D, Lip GYH. Plasma von Willebrand factor, fibrinogen and soluble P-selectin levels in paroxysmal, persistent and permanent atrial fibrillation. Effects of cardioversion and return of left atrial function. Eur Heart J 2001; 22: 1741-7.
23. Korantzopoulos P, Kolettis TM, Kountouris E et al. Oral vitamin C administration reduces early recurrence rates after electrical cardioversion of persistent atrial fibrillation and attenuates associated inflammation. Int J Cardiol (in press).
24. Siu CW, Lau CP, Tse HF. Prevention of atrial fibrillation recurrence by statin therapy in patients with lone atrial fibrillation after successful cardioversion. Am J Cardiol 2003; 92: 1343-5.
25. Young-Xu Y, Jabbour S, Goldberg R et al. Usefulness of statin drugs in protecting against atrial fibrillation in patients with coronary artery disease. Am J Cardiol 2003; 92: 1379-83.
26. Korantzopoulos P, Kountouris E, Kolettis T, Siogas K. Anti-inflammatory and antioxidant actions of statins may favorably affect atrial remodeling in atrial fibrillation. Am J Cardiol 2004; 93: 1200.
27. Dernellis J, Panaretou M. Relationship between C-reactive protein concentrations during glucocorticoid therapy and recurrent atrial fibrillation. Eur Heart J 2004; 25: 1100-7.
28. Abdelhadi RH, Chung MK, Van Wagoner DR. New hope for the prevention of recurrent atrial fibrillation. Eur Heart J 2004; 25: 1089-90.
29. Manios EG, Mavrakis HE, Kanoupakis EM et al. Effects of amiodarone and diltiazem on persistent atrial fibrillation conversion and recurrence rates: A randomized controlled study. Cardiovasc Drugs Ther 2003; 17: 31-9.
30. Ueng KC, Tsai TP, Yu WC et al. Use of enalapril to facilitate sinus rhythm maintenance after external cardioversion of long-standing persistent atrial fibrillation: Results of a prospective and controlled study. Eur Heart J 2003; 24: 2090-8.
31. Korantzopoulos P, Kolettis T, Kountouris E, Siogas K. Atrial remodeling in persistent atrial fibrillation: The potential role of aldosterone. Eur Heart J 2004; 25: 1086.